Print Page

Other safety alerts

 
Canada: “Control-Max”, an unauthorized product sold for sexual enhancement, may pose serious health risks
 
Health Canada advised that the unauthorized product “Control-Max” may pose serious health risks as it is labelled to contain a prescription drug (yohimbine). The product was being sold online by the company RGR Canada Inc.

Health Canada advised consumers to stop using the product and consult with their health care professionals if they have used this product and have health concerns.

In Canada, yohimbine is a prescription drug and should be used only under the supervision of a health care professional. The use of drugs containing yohimbine (either as yohimbine hydrochloride or yohimbe bark extract) may result in serious adverse reactions, particularly in people with high blood pressure, or heart, kidney or liver disease. Side effects associated with yohimbine include increased blood pressure and heart rate, anxiety, dizziness, tremors, headache, nausea and sleep disorders. It should not be used by children, or pregnant or nursing women.

Please refer to the following website in Health Canada for details: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/../61378a-eng.php

In Hong Kong, the above product is not a registered pharmaceutical product. All products containing yohimbine must be registered as pharmaceutical products before they can be sold, offered for sale, distributed or possessed for the purposes of sales, distribution or other use in Hong Kong. The registration number for a registered pharmaceutical product should be labelled on the sales pack in the form of "HK-XXXXX". The information of all registered pharmaceutical products can be identified from the Drug Office website at the following link:http://www.drugoffice.gov.hk/eps/do/../search_drug_database.html .


Ends/ Saturday, December 10, 2016
Issued at HKT 12:00
 
 
back